Covaxin
Drugs control committee extends shelf life of Bharat Biotech's Covaxin to 12 months
Currently, Covaxin has a shelf life of 6 months with subject to its storage at 2-8 degrees celsius
Australia adds Covaxin to list of 'recognised' COVID-19 vaccines
COVID-19 vaccines are approved for use in Australia by the Therapeutic Goods Administration after an assessment and approval process
Bharat Biotech's Covaxin finds place in Oman's list of approved COVID-19 vaccines
All passengers who have received two doses of Covaxin atleast 14 days before the estimated arrival date can travel to Oman
Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trials
Ocugen has already sought regulatory approval from Health Canada for Covaxin to be used in that country
WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin
The clarifications are sought to conduct a final 'risk-benefit assessment' for Emergency Use Listing of the vaccine
India committed to supplying COVID-19 vaccines to other nations by year end
India had suspended exports of COVID-19 vaccines in April
EUL decision on Covaxin awaited, WHO official says process sometimes takes longer
Soumya Swaminathan had earlier said that the technical advisory group at WHO will meet on October 26
WHO chief calls Mansukh Mandviya; discusses Covaxin, resuming AstraZeneca vaccine
The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues
WHO to meet next week to consider emergency use listing of Covaxin
Hyderabad-based Bharat Biotech had submitted Expression of Interest on April 19 for its vaccine
AA Edit | Validation glimmer for Covaxin, hope for parents
The two-dose vaccine will be administered with a gap of 28 days